Drug Type siRNA |
Synonyms- |
Target |
Action inhibitors |
Mechanism FAM13A inhibitors(family with sequence similarity 13 member A inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myocardial Infarction | Preclinical | United States | 14 Mar 2024 | |
Nonalcoholic Steatohepatitis | Preclinical | United States | 14 Mar 2024 | |
Obesity | Preclinical | United States | 14 Mar 2024 |